Twist Bioscience Corp — Revenue by Fiscal Year
9 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/964fe4ed-7594-4cb0-be1b-03eda10d3225/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $376.6M | 2024-10-01 – 2025-09-30 | evidence 0001581280-25-000025 |
| FY 2024 | $313.0M | 2023-10-01 – 2024-09-30 | evidence 0001628280-24-048262 |
| FY 2023 | $245.1M | 2022-10-01 – 2023-09-30 | evidence 0001628280-23-039767 |
| FY 2022 | $203.6M | 2021-10-01 – 2022-09-30 | evidence 0001628280-22-030817 |
| FY 2021 | $132.3M | 2020-10-01 – 2021-09-30 | evidence 0001104659-21-142700 |
| FY 2020 | $90.1M | 2019-10-01 – 2020-09-30 | evidence 0001193125-20-303904 |
| FY 2019 | $54.4M | 2018-10-01 – 2019-09-30 | evidence 0001193125-19-313115 |
| FY 2018 | $25.4M | 2017-10-01 – 2018-09-30 | evidence 0001193125-19-313115 |
| FY 2017 | $10.8M | 2016-10-01 – 2017-09-30 | evidence 0001193125-19-313115 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Twist Bioscience Corp — all facts · Net Income · Operating Income